EA036615B1 - Применение комплекса, облегчающего транскрипцию хроматина (fact), при раке - Google Patents

Info

Publication number

EA036615B1

EA036615B1 EA201591304A EA201591304A EA036615B1 EA 036615 B1 EA036615 B1 EA 036615B1 EA 201591304 A EA201591304 A EA 201591304A EA 201591304 A EA201591304 A EA 201591304A EA 036615 B1 EA036615 B1 EA 036615B1

Authority

EA

Eurasian Patent Office

Prior art keywords

tumor

ssrp1

cells

cancer

fact

Prior art date

2013-02-11

Links

• Espacenet
• Global Dossier
• Discuss

• 206010028980 Neoplasm Diseases 0.000 title claims abstract description 428
• 238000013518 transcription Methods 0.000 title claims abstract description 20
• 230000035897 transcription Effects 0.000 title claims abstract description 20
• 108010077544 Chromatin Proteins 0.000 title claims abstract description 18
• 210000003483 chromatin Anatomy 0.000 title claims abstract description 18
• 201000011510 cancer Diseases 0.000 title claims description 179
• 102100028166 FACT complex subunit SSRP1 Human genes 0.000 claims description 185
• 210000004027 cell Anatomy 0.000 claims description 171
• 101150097243 SPT16 gene Proteins 0.000 claims description 104
• 101100422204 Candida albicans (strain SC5314 / ATCC MYA-2876) CDC68 gene Proteins 0.000 claims description 102
• 101100422210 Drosophila melanogaster dre4 gene Proteins 0.000 claims description 102
• 101100043306 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) ctc-2 gene Proteins 0.000 claims description 102
• 210000001519 tissue Anatomy 0.000 claims description 90
• 238000000034 method Methods 0.000 claims description 49
• 210000004881 tumor cell Anatomy 0.000 claims description 41
• 108090000623 proteins and genes Proteins 0.000 claims description 34
• 238000001574 biopsy Methods 0.000 claims description 32
• 230000004083 survival effect Effects 0.000 claims description 31
• 208000026310 Breast neoplasm Diseases 0.000 claims description 27
• 238000009098 adjuvant therapy Methods 0.000 claims description 25
• 102000004169 proteins and genes Human genes 0.000 claims description 25
• 238000009099 neoadjuvant therapy Methods 0.000 claims description 23
• 238000010186 staining Methods 0.000 claims description 19
• 239000003795 chemical substances by application Substances 0.000 claims description 18
• 238000001262 western blot Methods 0.000 claims description 15
• 210000000496 pancreas Anatomy 0.000 claims description 13
• 206010027476 Metastases Diseases 0.000 claims description 12
• 210000003734 kidney Anatomy 0.000 claims description 12
• 238000005259 measurement Methods 0.000 claims description 12
• 238000004458 analytical method Methods 0.000 claims description 11
• 101000697353 Homo sapiens FACT complex subunit SSRP1 Proteins 0.000 claims description 10
• 238000011532 immunohistochemical staining Methods 0.000 claims description 10
• 210000004072 lung Anatomy 0.000 claims description 10
• 230000009401 metastasis Effects 0.000 claims description 10
• 210000001072 colon Anatomy 0.000 claims description 8
• 238000003125 immunofluorescent labeling Methods 0.000 claims description 8
• 230000007423 decrease Effects 0.000 claims description 6
• 210000002307 prostate Anatomy 0.000 claims description 6
• 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims description 5
• 210000004748 cultured cell Anatomy 0.000 claims description 5
• 230000036210 malignancy Effects 0.000 claims description 5
• 210000003169 central nervous system Anatomy 0.000 claims description 4
• 210000003679 cervix uteri Anatomy 0.000 claims description 4
• 210000003128 head Anatomy 0.000 claims description 4
• 210000004185 liver Anatomy 0.000 claims description 4
• 210000003739 neck Anatomy 0.000 claims description 4
• 210000001672 ovary Anatomy 0.000 claims description 4
• 210000001428 peripheral nervous system Anatomy 0.000 claims description 4
• 210000000664 rectum Anatomy 0.000 claims description 4
• 230000000306 recurrent effect Effects 0.000 claims description 4
• 210000003491 skin Anatomy 0.000 claims description 4
• 239000000439 tumor marker Substances 0.000 claims description 4
• 210000003932 urinary bladder Anatomy 0.000 claims description 4
• 238000002965 ELISA Methods 0.000 claims description 3
• 210000000448 cultured tumor cell Anatomy 0.000 claims 1
• 238000011282 treatment Methods 0.000 abstract description 46
• 101710100450 FACT complex subunit SSRP1 Proteins 0.000 description 176
• 239000000523 sample Substances 0.000 description 61
• 230000014509 gene expression Effects 0.000 description 57
• 210000000130 stem cell Anatomy 0.000 description 44
• -1 for example Chemical compound 0.000 description 37
• 238000011256 aggressive treatment Methods 0.000 description 33
• 230000003211 malignant effect Effects 0.000 description 31
• 206010061289 metastatic neoplasm Diseases 0.000 description 30
• 238000001514 detection method Methods 0.000 description 27
• 108020004999 messenger RNA Proteins 0.000 description 26
• 230000001394 metastastic effect Effects 0.000 description 26
• 238000002512 chemotherapy Methods 0.000 description 25
• 206010006187 Breast cancer Diseases 0.000 description 24
• 238000003556 assay Methods 0.000 description 23
• 108091027967 Small hairpin RNA Proteins 0.000 description 21
• 239000002246 antineoplastic agent Substances 0.000 description 19
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
• 230000003902 lesion Effects 0.000 description 16
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 16
• 229940127089 cytotoxic agent Drugs 0.000 description 15
• 201000010099 disease Diseases 0.000 description 15
• 210000002950 fibroblast Anatomy 0.000 description 15
• 239000002671 adjuvant Substances 0.000 description 14
• 230000004044 response Effects 0.000 description 14
• 239000004055 small Interfering RNA Substances 0.000 description 14
• 231100000419 toxicity Toxicity 0.000 description 14
• 230000001988 toxicity Effects 0.000 description 14
• 208000006265 Renal cell carcinoma Diseases 0.000 description 13
• 210000000481 breast Anatomy 0.000 description 13
• 230000012010 growth Effects 0.000 description 13
• 238000000338 in vitro Methods 0.000 description 13
• 238000002638 palliative care Methods 0.000 description 13
• 210000002919 epithelial cell Anatomy 0.000 description 12
• 238000010361 transduction Methods 0.000 description 12
• 230000026683 transduction Effects 0.000 description 12
• 108020004414 DNA Proteins 0.000 description 10
• 208000020816 lung neoplasm Diseases 0.000 description 10
• 238000001959 radiotherapy Methods 0.000 description 10
• 238000011269 treatment regimen Methods 0.000 description 10
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 9
• 239000012634 fragment Substances 0.000 description 9
• 238000004393 prognosis Methods 0.000 description 9
• 230000009466 transformation Effects 0.000 description 9
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
• 241000238017 Astacoidea Species 0.000 description 8
• 241000699666 Mus <mouse, genus> Species 0.000 description 8
• 230000000694 effects Effects 0.000 description 8
• 210000004907 gland Anatomy 0.000 description 8
• 239000000463 material Substances 0.000 description 8
• 150000007523 nucleic acids Chemical class 0.000 description 8
• 210000000056 organ Anatomy 0.000 description 8
• 229950010131 puromycin Drugs 0.000 description 8
• 102100038595 Estrogen receptor Human genes 0.000 description 7
• 101000836111 Homo sapiens FACT complex subunit SPT16 Proteins 0.000 description 7
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 7
• 239000003153 chemical reaction reagent Substances 0.000 description 7
• 238000004590 computer program Methods 0.000 description 7
• 108010038795 estrogen receptors Proteins 0.000 description 7
• 201000005202 lung cancer Diseases 0.000 description 7
• 239000003550 marker Substances 0.000 description 7
• 238000011227 neoadjuvant chemotherapy Methods 0.000 description 7
• 230000008569 process Effects 0.000 description 7
• 238000012360 testing method Methods 0.000 description 7
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
• 201000009030 Carcinoma Diseases 0.000 description 6
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 6
• 206010009944 Colon cancer Diseases 0.000 description 6
• 102100025637 FACT complex subunit SPT16 Human genes 0.000 description 6
• 206010060862 Prostate cancer Diseases 0.000 description 6
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 6
• 239000000427 antigen Substances 0.000 description 6
• 108091007433 antigens Proteins 0.000 description 6
• 102000036639 antigens Human genes 0.000 description 6
• 230000008901 benefit Effects 0.000 description 6
• 229960004316 cisplatin Drugs 0.000 description 6
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 6
• 239000002299 complementary DNA Substances 0.000 description 6
• 238000002591 computed tomography Methods 0.000 description 6
• 238000002474 experimental method Methods 0.000 description 6
• 238000003384 imaging method Methods 0.000 description 6
• 239000003112 inhibitor Substances 0.000 description 6
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 6
• 102000039446 nucleic acids Human genes 0.000 description 6
• 108020004707 nucleic acids Proteins 0.000 description 6
• 230000010076 replication Effects 0.000 description 6
• 238000001356 surgical procedure Methods 0.000 description 6
• 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 6
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 5
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 5
• 102100038081 Signal transducer CD24 Human genes 0.000 description 5
• 230000027455 binding Effects 0.000 description 5
• 210000001124 body fluid Anatomy 0.000 description 5
• 239000010839 body fluid Substances 0.000 description 5
• 208000029742 colonic neoplasm Diseases 0.000 description 5
• 238000003745 diagnosis Methods 0.000 description 5
• 239000003814 drug Substances 0.000 description 5
• 239000000284 extract Substances 0.000 description 5
• 238000010166 immunofluorescence Methods 0.000 description 5
• 230000002055 immunohistochemical effect Effects 0.000 description 5
• 210000001165 lymph node Anatomy 0.000 description 5
• 230000007246 mechanism Effects 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 230000001575 pathological effect Effects 0.000 description 5
• 238000010837 poor prognosis Methods 0.000 description 5
• 102000003998 progesterone receptors Human genes 0.000 description 5
• 108090000468 progesterone receptors Proteins 0.000 description 5
• 230000005855 radiation Effects 0.000 description 5
• 102100040753 Casein kinase II subunit alpha' Human genes 0.000 description 4
• 101150029707 ERBB2 gene Proteins 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 101000892015 Homo sapiens Casein kinase II subunit alpha' Proteins 0.000 description 4
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 4
• 241000713666 Lentivirus Species 0.000 description 4
• 108010072866 Prostate-Specific Antigen Proteins 0.000 description 4
• 102100038358 Prostate-specific antigen Human genes 0.000 description 4
• 238000011529 RT qPCR Methods 0.000 description 4
• NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 4
• 108010017842 Telomerase Proteins 0.000 description 4
• 102100027881 Tumor protein 63 Human genes 0.000 description 4
• 101710140697 Tumor protein 63 Proteins 0.000 description 4
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 4
• 208000009956 adenocarcinoma Diseases 0.000 description 4
• 238000011226 adjuvant chemotherapy Methods 0.000 description 4
• 230000010261 cell growth Effects 0.000 description 4
• 238000011254 conventional chemotherapy Methods 0.000 description 4
• 230000034994 death Effects 0.000 description 4
• 229940088598 enzyme Drugs 0.000 description 4
• 229960002949 fluorouracil Drugs 0.000 description 4
• 230000036541 health Effects 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 238000011221 initial treatment Methods 0.000 description 4
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 4
• 238000002493 microarray Methods 0.000 description 4
• 238000013188 needle biopsy Methods 0.000 description 4
• 230000002018 overexpression Effects 0.000 description 4
• 201000002528 pancreatic cancer Diseases 0.000 description 4
• 208000008443 pancreatic carcinoma Diseases 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 230000035755 proliferation Effects 0.000 description 4
• 238000011002 quantification Methods 0.000 description 4
• 230000002285 radioactive effect Effects 0.000 description 4
• 229940124597 therapeutic agent Drugs 0.000 description 4
• AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 description 3
• 102000004121 Annexin A5 Human genes 0.000 description 3
• 108090000672 Annexin A5 Proteins 0.000 description 3
• 206010005003 Bladder cancer Diseases 0.000 description 3
• JKCSODVERGVDLT-UHFFFAOYSA-N CBL0137 Chemical compound CC(=O)C1=CC=C2N(CCNC(C)C)C3=CC=C(C(C)=O)C=C3C2=C1 JKCSODVERGVDLT-UHFFFAOYSA-N 0.000 description 3
• 102100032912 CD44 antigen Human genes 0.000 description 3
• DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 3
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 3
• 206010061818 Disease progression Diseases 0.000 description 3
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
• 238000012286 ELISA Assay Methods 0.000 description 3
• HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 description 3
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 3
• 101000971144 Homo sapiens Tyrosine-protein kinase BAZ1B Proteins 0.000 description 3
• 208000008839 Kidney Neoplasms Diseases 0.000 description 3
• 241001465754 Metazoa Species 0.000 description 3
• ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 3
• 108700020796 Oncogene Proteins 0.000 description 3
• 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 3
• 229930012538 Paclitaxel Natural products 0.000 description 3
• 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 3
• 206010038389 Renal cancer Diseases 0.000 description 3
• 102100021575 Tyrosine-protein kinase BAZ1B Human genes 0.000 description 3
• 241000700605 Viruses Species 0.000 description 3
• 239000003242 anti bacterial agent Substances 0.000 description 3
• 229940088710 antibiotic agent Drugs 0.000 description 3
• VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 3
• 229960002685 biotin Drugs 0.000 description 3
• 235000020958 biotin Nutrition 0.000 description 3
• 239000011616 biotin Substances 0.000 description 3
• 229960004562 carboplatin Drugs 0.000 description 3
• 229960005243 carmustine Drugs 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 238000004163 cytometry Methods 0.000 description 3
• 230000005750 disease progression Effects 0.000 description 3
• 229960003668 docetaxel Drugs 0.000 description 3
• 229960004679 doxorubicin Drugs 0.000 description 3
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 3
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 3
• 229960001904 epirubicin Drugs 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 239000000833 heterodimer Substances 0.000 description 3
• 108091008039 hormone receptors Proteins 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 238000002721 intensity-modulated radiation therapy Methods 0.000 description 3
• 201000010982 kidney cancer Diseases 0.000 description 3
• 239000000203 mixture Substances 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 3
• 210000004882 non-tumor cell Anatomy 0.000 description 3
• 229960001592 paclitaxel Drugs 0.000 description 3
• 201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 description 3
• 239000012188 paraffin wax Substances 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 230000001105 regulatory effect Effects 0.000 description 3
• 238000003757 reverse transcription PCR Methods 0.000 description 3
• 239000002356 single layer Substances 0.000 description 3
• 210000002536 stromal cell Anatomy 0.000 description 3
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 229960000303 topotecan Drugs 0.000 description 3
• UCFGDBYHRUNTLO-QHCPKHFHSA-N topotecan Chemical compound C1=C(O)C(CN(C)C)=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UCFGDBYHRUNTLO-QHCPKHFHSA-N 0.000 description 3
• 230000004614 tumor growth Effects 0.000 description 3
• 201000005112 urinary bladder cancer Diseases 0.000 description 3
• 239000013598 vector Substances 0.000 description 3
• 238000012800 visualization Methods 0.000 description 3
• VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 description 2
• NMUSYJAQQFHJEW-UHFFFAOYSA-N 5-Azacytidine Natural products O=C1N=C(N)N=CN1C1C(O)C(O)C(CO)O1 NMUSYJAQQFHJEW-UHFFFAOYSA-N 0.000 description 2
• NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 description 2
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
• 108010085238 Actins Proteins 0.000 description 2
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N Adenosine Natural products C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 102100038910 Alpha-enolase Human genes 0.000 description 2
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 2
• 108700020463 BRCA1 Proteins 0.000 description 2
• 101150072950 BRCA1 gene Proteins 0.000 description 2
• 108010006654 Bleomycin Proteins 0.000 description 2
• 102100025401 Breast cancer type 1 susceptibility protein Human genes 0.000 description 2
• 102100027992 Casein kinase II subunit beta Human genes 0.000 description 2
• 206010008342 Cervix carcinoma Diseases 0.000 description 2
• 102000010792 Chromogranin A Human genes 0.000 description 2
• 108010038447 Chromogranin A Proteins 0.000 description 2
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
• 102100031519 Collagen alpha-1(VI) chain Human genes 0.000 description 2
• 108050006400 Cyclin Proteins 0.000 description 2
• 102100033245 Cyclin-dependent kinase 16 Human genes 0.000 description 2
• 102100024458 Cyclin-dependent kinase inhibitor 2A Human genes 0.000 description 2
• 108010037462 Cyclooxygenase 2 Proteins 0.000 description 2
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
• UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 2
• 241000283073 Equus caballus Species 0.000 description 2
• 201000008808 Fibrosarcoma Diseases 0.000 description 2
• BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 2
• 108010069236 Goserelin Proteins 0.000 description 2
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
• 101000892026 Homo sapiens Casein kinase II subunit alpha Proteins 0.000 description 2
• 101000858625 Homo sapiens Casein kinase II subunit beta Proteins 0.000 description 2
• 101000941581 Homo sapiens Collagen alpha-1(VI) chain Proteins 0.000 description 2
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
• 101000582404 Homo sapiens Replication factor C subunit 4 Proteins 0.000 description 2
• 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 description 2
• 101000588553 Homo sapiens Serine/threonine-protein kinase Nek9 Proteins 0.000 description 2
• 101000807631 Homo sapiens UAP56-interacting factor Proteins 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 description 2
• XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 description 2
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
• 102000010790 Interleukin-3 Receptors Human genes 0.000 description 2
• 108010038452 Interleukin-3 Receptors Proteins 0.000 description 2
• 102000011782 Keratins Human genes 0.000 description 2
• 108010076876 Keratins Proteins 0.000 description 2
• 239000005551 L01XE03 - Erlotinib Substances 0.000 description 2
• 229930192392 Mitomycin Natural products 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
• 108091028043 Nucleic acid sequence Proteins 0.000 description 2
• 102100022678 Nucleophosmin Human genes 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 102000010752 Plasminogen Inactivators Human genes 0.000 description 2
• 108010077971 Plasminogen Inactivators Proteins 0.000 description 2
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
• 102100036691 Proliferating cell nuclear antigen Human genes 0.000 description 2
• 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 2
• 101710120463 Prostate stem cell antigen Proteins 0.000 description 2
• 102100036735 Prostate stem cell antigen Human genes 0.000 description 2
• 102100035703 Prostatic acid phosphatase Human genes 0.000 description 2
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
• 102100030542 Replication factor C subunit 4 Human genes 0.000 description 2
• 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 description 2
• 102100031398 Serine/threonine-protein kinase Nek9 Human genes 0.000 description 2
• 108020004459 Small interfering RNA Proteins 0.000 description 2
• 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 2
• 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 2
• 102100037229 UAP56-interacting factor Human genes 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 2
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 2
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
• 229940045799 anthracyclines and related substance Drugs 0.000 description 2
• 230000001093 anti-cancer Effects 0.000 description 2
• 230000000340 anti-metabolite Effects 0.000 description 2
• 229940100197 antimetabolite Drugs 0.000 description 2
• 239000002256 antimetabolite Substances 0.000 description 2
• 229960002756 azacitidine Drugs 0.000 description 2
• 102000015736 beta 2-Microglobulin Human genes 0.000 description 2
• 108010081355 beta 2-Microglobulin Proteins 0.000 description 2
• 239000000090 biomarker Substances 0.000 description 2
• 229960001561 bleomycin Drugs 0.000 description 2
• OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
• 201000008274 breast adenocarcinoma Diseases 0.000 description 2
• 201000008275 breast carcinoma Diseases 0.000 description 2
• 201000010881 cervical cancer Diseases 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 238000000546 chi-square test Methods 0.000 description 2
• 229960004397 cyclophosphamide Drugs 0.000 description 2
• 230000003247 decreasing effect Effects 0.000 description 2
• 108700041286 delta Proteins 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 208000035475 disorder Diseases 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• AAKJLRGGTJKAMG-UHFFFAOYSA-N erlotinib Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=NC=1NC1=CC=CC(C#C)=C1 AAKJLRGGTJKAMG-UHFFFAOYSA-N 0.000 description 2
• LVZYXEALRXBLJZ-ISQYCPACSA-N f60ne4xb53 Chemical compound N1([C@@H]2O[C@@H]([C@H](C2)NP(O)(=S)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)NP(S)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)N)COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)N[C@H]2C[C@@H](O[C@@H]2COP(O)(=S)OCC(O)CNC(=O)CCCCCCCCCCCCCCC)N2C(NC(=O)C(C)=C2)=O)N2C3=NC=NC(N)=C3N=C2)N2C3=C(C(NC(N)=N3)=O)N=C2)N2C3=C(C(NC(N)=N3)=O)N=C2)N2C3=C(C(NC(N)=N3)=O)N=C2)N2C(NC(=O)C(C)=C2)=O)N2C(NC(=O)C(C)=C2)=O)N2C3=NC=NC(N)=C3N=C2)N2C3=C(C(NC(N)=N3)=O)N=C2)N2C3=NC=NC(N)=C3N=C2)C=CC(N)=NC1=O LVZYXEALRXBLJZ-ISQYCPACSA-N 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 238000000799 fluorescence microscopy Methods 0.000 description 2
• 238000013467 fragmentation Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 230000006870 function Effects 0.000 description 2
• 229960005277 gemcitabine Drugs 0.000 description 2
• SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 2
• 230000004547 gene signature Effects 0.000 description 2
• 238000003205 genotyping method Methods 0.000 description 2
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
• 229940066919 hepcidin Drugs 0.000 description 2
• JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
• 229960000908 idarubicin Drugs 0.000 description 2
• 229960001101 ifosfamide Drugs 0.000 description 2
• HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 2
• 229950004291 imetelstat Drugs 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• GURKHSYORGJETM-WAQYZQTGSA-N irinotecan hydrochloride (anhydrous) Chemical compound Cl.C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 GURKHSYORGJETM-WAQYZQTGSA-N 0.000 description 2
• 229940043355 kinase inhibitor Drugs 0.000 description 2
• 208000003849 large cell carcinoma Diseases 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 238000001325 log-rank test Methods 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 210000005075 mammary gland Anatomy 0.000 description 2
• CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 2
• 229960000907 methylthioninium chloride Drugs 0.000 description 2
• 229960004857 mitomycin Drugs 0.000 description 2
• 230000036457 multidrug resistance Effects 0.000 description 2
• 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 2
• FWLMVFUGMHIOAA-UHFFFAOYSA-N n-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide Chemical compound C1=CC(C(=O)NC)=CC=C1NC1=NC=C(C(F)(F)F)C(NCC=2C(=NC=CN=2)N(C)S(C)(=O)=O)=N1 FWLMVFUGMHIOAA-UHFFFAOYSA-N 0.000 description 2
• 239000002853 nucleic acid probe Substances 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical group 0.000 description 2
• 229960001756 oxaliplatin Drugs 0.000 description 2
• DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 2
• 201000010198 papillary carcinoma Diseases 0.000 description 2
• 230000000737 periodic effect Effects 0.000 description 2
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 2
• 239000002797 plasminogen activator inhibitor Substances 0.000 description 2
• BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
• KVEZNWYEYNDLSN-UHFFFAOYSA-N propyl 3-bromo-2-oxopropanoate Chemical compound CCCOC(=O)C(=O)CBr KVEZNWYEYNDLSN-UHFFFAOYSA-N 0.000 description 2
• 108010043671 prostatic acid phosphatase Proteins 0.000 description 2
• 238000009666 routine test Methods 0.000 description 2
• 208000014212 sarcomatoid carcinoma Diseases 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 206010041823 squamous cell carcinoma Diseases 0.000 description 2
• 238000012289 standard assay Methods 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 229960001603 tamoxifen Drugs 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
• 229960003048 vinblastine Drugs 0.000 description 2
• JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 2
• 229960004528 vincristine Drugs 0.000 description 2
• OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 2
• OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 2
• 229960002066 vinorelbine Drugs 0.000 description 2
• GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 description 2
• 230000002618 waking effect Effects 0.000 description 2
• 230000003442 weekly effect Effects 0.000 description 2
• XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
• XJOTXKZIRSHZQV-RXHOOSIZSA-N (3S)-3-amino-4-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S,3S)-1-[[(1R,6R,12R,17R,20S,23S,26R,31R,34R,39R,42S,45S,48S,51S,59S)-51-(4-aminobutyl)-31-[[(2S)-6-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]carbamoyl]-20-benzyl-23-[(2S)-butan-2-yl]-45-(3-carbamimidamidopropyl)-48-(hydroxymethyl)-42-(1H-imidazol-4-ylmethyl)-59-(2-methylsulfanylethyl)-7,10,19,22,25,33,40,43,46,49,52,54,57,60,63,64-hexadecaoxo-3,4,14,15,28,29,36,37-octathia-8,11,18,21,24,32,41,44,47,50,53,55,58,61,62,65-hexadecazatetracyclo[32.19.8.26,17.212,39]pentahexacontan-26-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)[C@@H](C)O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](Cc5ccccc5)NC(=O)[C@@H](NC1=O)[C@@H](C)CC)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc1cnc[nH]1)NC3=O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N2)C(=O)NCC(=O)N4)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XJOTXKZIRSHZQV-RXHOOSIZSA-N 0.000 description 1
• DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
• FPVKHBSQESCIEP-UHFFFAOYSA-N (8S)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol Natural products C1C(O)C(CO)OC1N1C(NC=NCC2O)=C2N=C1 FPVKHBSQESCIEP-UHFFFAOYSA-N 0.000 description 1
• FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 1
• ZGNLFUXWZJGETL-YUSKDDKASA-N (Z)-[(2S)-2-amino-2-carboxyethyl]-hydroxyimino-oxidoazanium Chemical compound N[C@@H](C\[N+]([O-])=N\O)C(O)=O ZGNLFUXWZJGETL-YUSKDDKASA-N 0.000 description 1
• 102100040685 14-3-3 protein zeta/delta Human genes 0.000 description 1
• 108020004463 18S ribosomal RNA Proteins 0.000 description 1
• PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
• RAYNZUHYMMLQQA-ZEQRLZLVSA-N 2,3,5-trihydroxy-7-methyl-n-[(2r)-2-phenylpropyl]-6-[1,6,7-trihydroxy-3-methyl-5-[[(2r)-2-phenylpropyl]carbamoyl]naphthalen-2-yl]naphthalene-1-carboxamide Chemical compound C1([C@@H](C)CNC(=O)C=2C3=CC(C)=C(C(=C3C=C(O)C=2O)O)C=2C(O)=C3C=C(O)C(O)=C(C3=CC=2C)C(=O)NC[C@H](C)C=2C=CC=CC=2)=CC=CC=C1 RAYNZUHYMMLQQA-ZEQRLZLVSA-N 0.000 description 1
• DIDGPCDGNMIUNX-UUOKFMHZSA-N 2-amino-9-[(2r,3r,4s,5r)-5-(dihydroxyphosphinothioyloxymethyl)-3,4-dihydroxyoxolan-2-yl]-3h-purin-6-one Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=S)[C@@H](O)[C@H]1O DIDGPCDGNMIUNX-UUOKFMHZSA-N 0.000 description 1
• DYNFCHNNOHNJFG-UHFFFAOYSA-M 2-formylbenzoate Chemical compound [O-]C(=O)C1=CC=CC=C1C=O DYNFCHNNOHNJFG-UHFFFAOYSA-M 0.000 description 1
• 102100032282 26S proteasome non-ATPase regulatory subunit 14 Human genes 0.000 description 1
• 102100032303 26S proteasome non-ATPase regulatory subunit 2 Human genes 0.000 description 1
• 102100039377 28 kDa heat- and acid-stable phosphoprotein Human genes 0.000 description 1
• 102100028831 28S ribosomal protein S6, mitochondrial Human genes 0.000 description 1
• NDMPLJNOPCLANR-UHFFFAOYSA-N 3,4-dihydroxy-15-(4-hydroxy-18-methoxycarbonyl-5,18-seco-ibogamin-18-yl)-16-methoxy-1-methyl-6,7-didehydro-aspidospermidine-3-carboxylic acid methyl ester Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 NDMPLJNOPCLANR-UHFFFAOYSA-N 0.000 description 1
• WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 1
• 102100040842 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 Human genes 0.000 description 1
• 102100026188 3-hydroxybutyrate dehydrogenase type 2 Human genes 0.000 description 1
• HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
• 102100034088 40S ribosomal protein S4, X isoform Human genes 0.000 description 1
• 102100033400 4F2 cell-surface antigen heavy chain Human genes 0.000 description 1
• FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 1
• 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
• 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
• VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 1
• STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
• CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
• 102000051388 ADAMTS1 Human genes 0.000 description 1
• 108091005660 ADAMTS1 Proteins 0.000 description 1
• 102100026396 ADP/ATP translocase 2 Human genes 0.000 description 1
• 101150023956 ALK gene Proteins 0.000 description 1
• 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 1
• 102100022974 AP-2 complex subunit alpha-2 Human genes 0.000 description 1
• 102100033347 AP-2 complex subunit beta Human genes 0.000 description 1
• 102100034580 AT-rich interactive domain-containing protein 1A Human genes 0.000 description 1
• 102100020973 ATP-binding cassette sub-family D member 3 Human genes 0.000 description 1
• 102100039864 ATPase family AAA domain-containing protein 2 Human genes 0.000 description 1
• 102100022117 Abnormal spindle-like microcephaly-associated protein Human genes 0.000 description 1
• 102100033639 Acetylcholinesterase Human genes 0.000 description 1
• 108010022752 Acetylcholinesterase Proteins 0.000 description 1
• 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
• 102100030374 Actin, cytoplasmic 2 Human genes 0.000 description 1
• 102100034064 Actin-like protein 6A Human genes 0.000 description 1
• 102100033888 Actin-related protein 2/3 complex subunit 4 Human genes 0.000 description 1
• 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 description 1
• 101710194155 Adenylate cyclase type 1 Proteins 0.000 description 1
• 102100032153 Adenylate cyclase type 8 Human genes 0.000 description 1
• 102100040023 Adhesion G-protein coupled receptor G6 Human genes 0.000 description 1
• 108010000239 Aequorin Proteins 0.000 description 1
• 102100021266 Alpha-(1,6)-fucosyltransferase Human genes 0.000 description 1
• 101710119858 Alpha-1-acid glycoprotein Proteins 0.000 description 1
• 201000003076 Angiosarcoma Diseases 0.000 description 1
• 102000004149 Annexin A2 Human genes 0.000 description 1
• 108090000668 Annexin A2 Proteins 0.000 description 1
• 102000004148 Annexin A4 Human genes 0.000 description 1
• 108090000669 Annexin A4 Proteins 0.000 description 1
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
• 102100024365 Arf-GAP domain and FG repeat-containing protein 1 Human genes 0.000 description 1
• 229940122815 Aromatase inhibitor Drugs 0.000 description 1
• 102000015790 Asparaginase Human genes 0.000 description 1
• 108010024976 Asparaginase Proteins 0.000 description 1
• 102000004000 Aurora Kinase A Human genes 0.000 description 1
• 108090000461 Aurora Kinase A Proteins 0.000 description 1
• 102100032306 Aurora kinase B Human genes 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
• 108091012583 BCL2 Proteins 0.000 description 1
• 108091032955 Bacterial small RNA Proteins 0.000 description 1
• 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 1
• 102100027880 Basal body-orientation factor 1 Human genes 0.000 description 1
• FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 102100031173 CCN family member 4 Human genes 0.000 description 1
• 108700020472 CDC20 Proteins 0.000 description 1
• 101710083734 CTP synthase Proteins 0.000 description 1
• 102100039866 CTP synthase 1 Human genes 0.000 description 1
• 108090000835 CX3C Chemokine Receptor 1 Proteins 0.000 description 1
• 102100039196 CX3C chemokine receptor 1 Human genes 0.000 description 1
• 102100035680 Cadherin EGF LAG seven-pass G-type receptor 2 Human genes 0.000 description 1
• 102100024153 Cadherin-15 Human genes 0.000 description 1
• 102100029761 Cadherin-5 Human genes 0.000 description 1
• 101100327692 Caenorhabditis elegans hsp-60 gene Proteins 0.000 description 1
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
• 102000055006 Calcitonin Human genes 0.000 description 1
• 108060001064 Calcitonin Proteins 0.000 description 1
• 102100024436 Caldesmon Human genes 0.000 description 1
• 108010052500 Calgranulin A Proteins 0.000 description 1
• KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
• UJOBWOGCFQCDNV-UHFFFAOYSA-N Carbazole Natural products C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 1
• 102100035439 Carcinoembryonic antigen-related cell adhesion molecule 19 Human genes 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 102100025953 Cathepsin F Human genes 0.000 description 1
• 102100026540 Cathepsin L2 Human genes 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 101150023302 Cdc20 gene Proteins 0.000 description 1
• 102100038099 Cell division cycle protein 20 homolog Human genes 0.000 description 1
• 102100024479 Cell division cycle-associated protein 3 Human genes 0.000 description 1
• 108010091675 Cellular Apoptosis Susceptibility Protein Proteins 0.000 description 1
• 102100038503 Cellular retinoic acid-binding protein 1 Human genes 0.000 description 1
• 102000011682 Centromere Protein A Human genes 0.000 description 1
• 108010076303 Centromere Protein A Proteins 0.000 description 1
• 102100023344 Centromere protein F Human genes 0.000 description 1
• 102100031214 Centromere protein N Human genes 0.000 description 1
• 102100037635 Centromere protein U Human genes 0.000 description 1
• 102100033674 Centromere protein X Human genes 0.000 description 1
• 102100025832 Centromere-associated protein E Human genes 0.000 description 1
• 102100031219 Centrosomal protein of 55 kDa Human genes 0.000 description 1
• 101710092479 Centrosomal protein of 55 kDa Proteins 0.000 description 1
• 102100039219 Centrosome-associated protein CEP250 Human genes 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 102000018704 Chitinase-3-Like Protein 1 Human genes 0.000 description 1
• 108010066813 Chitinase-3-Like Protein 1 Proteins 0.000 description 1
• 102000009016 Cholera Toxin Human genes 0.000 description 1
• 108010049048 Cholera Toxin Proteins 0.000 description 1
• 102100038602 Chromatin assembly factor 1 subunit A Human genes 0.000 description 1
• 102100033682 Cilia- and flagella-associated protein 69 Human genes 0.000 description 1
• 101710082464 Cis-aconitate decarboxylase Proteins 0.000 description 1
• PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 description 1
• 102100021864 Cocaine esterase Human genes 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 102100029136 Collagen alpha-1(II) chain Human genes 0.000 description 1
• 102100031611 Collagen alpha-1(III) chain Human genes 0.000 description 1
• 102100032951 Condensin complex subunit 2 Human genes 0.000 description 1
• 102100040450 Connector enhancer of kinase suppressor of ras 1 Human genes 0.000 description 1
• 108010058546 Cyclin D1 Proteins 0.000 description 1
• 102100025191 Cyclin-A2 Human genes 0.000 description 1
• 102100024170 Cyclin-C Human genes 0.000 description 1
• 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
• 108010009392 Cyclin-Dependent Kinase Inhibitor p16 Proteins 0.000 description 1
• 108010016788 Cyclin-Dependent Kinase Inhibitor p21 Proteins 0.000 description 1
• 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 1
• 102100036329 Cyclin-dependent kinase 3 Human genes 0.000 description 1
• 102100033270 Cyclin-dependent kinase inhibitor 1 Human genes 0.000 description 1
• 102100034501 Cyclin-dependent kinases regulatory subunit 1 Human genes 0.000 description 1
• 102100032522 Cyclin-dependent kinases regulatory subunit 2 Human genes 0.000 description 1
• 102100026897 Cystatin-C Human genes 0.000 description 1
• 102100031461 Cytochrome P450 2J2 Human genes 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• 238000000116 DAPI staining Methods 0.000 description 1
• 102100037810 DEP domain-containing protein 1B Human genes 0.000 description 1
• 108090000323 DNA Topoisomerases Proteins 0.000 description 1
• 102000003915 DNA Topoisomerases Human genes 0.000 description 1
• 230000005778 DNA damage Effects 0.000 description 1
• 231100000277 DNA damage Toxicity 0.000 description 1
• 102100035186 DNA excision repair protein ERCC-1 Human genes 0.000 description 1
• 101710147299 DNA fragmentation factor subunit beta Proteins 0.000 description 1
• 238000000018 DNA microarray Methods 0.000 description 1
• 102100024829 DNA polymerase delta catalytic subunit Human genes 0.000 description 1
• 102100035474 DNA polymerase kappa Human genes 0.000 description 1
• 102100030960 DNA replication licensing factor MCM2 Human genes 0.000 description 1
• 102100039606 DNA replication licensing factor MCM3 Human genes 0.000 description 1
• 102100021389 DNA replication licensing factor MCM4 Human genes 0.000 description 1
• 102100033720 DNA replication licensing factor MCM6 Human genes 0.000 description 1
• 102100033587 DNA topoisomerase 2-alpha Human genes 0.000 description 1
• 102100032881 DNA-binding protein SATB1 Human genes 0.000 description 1
• 108010092160 Dactinomycin Proteins 0.000 description 1
• XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 102100022283 Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Human genes 0.000 description 1
• 102100021215 Denticleless protein homolog Human genes 0.000 description 1
• 102100029588 Deoxycytidine kinase Human genes 0.000 description 1
• 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
• 102100029921 Dipeptidyl peptidase 1 Human genes 0.000 description 1
• 206010061819 Disease recurrence Diseases 0.000 description 1
• 102100034108 DnaJ homolog subfamily C member 12 Human genes 0.000 description 1
• 102100029952 Double-strand-break repair protein rad21 homolog Human genes 0.000 description 1
• 101000801698 Drosophila melanogaster Tropomyosin-1, isoforms 9A/A/B Proteins 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• 102100027085 Dual specificity protein phosphatase 4 Human genes 0.000 description 1
• 102100024749 Dynein light chain Tctex-type 1 Human genes 0.000 description 1
• 102100027418 E3 ubiquitin-protein ligase RNF213 Human genes 0.000 description 1
• 102100029108 Elongation factor 1-alpha 2 Human genes 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 208000005431 Endometrioid Carcinoma Diseases 0.000 description 1
• 101710199605 Endoribonuclease Proteins 0.000 description 1
• 102100033902 Endothelin-1 Human genes 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 102100029055 Exostosin-1 Human genes 0.000 description 1
• 102100029091 Exportin-2 Human genes 0.000 description 1
• 102100020903 Ezrin Human genes 0.000 description 1
• 102100030421 Fatty acid-binding protein 5 Human genes 0.000 description 1
• 102100037733 Fatty acid-binding protein, brain Human genes 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102000009123 Fibrin Human genes 0.000 description 1
• 108010073385 Fibrin Proteins 0.000 description 1
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
• 102000008946 Fibrinogen Human genes 0.000 description 1
• 108010049003 Fibrinogen Proteins 0.000 description 1
• 238000000729 Fisher's exact test Methods 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• 102100026121 Flap endonuclease 1 Human genes 0.000 description 1
• 108090000652 Flap endonucleases Proteins 0.000 description 1
• 102000016621 Focal Adhesion Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108010067715 Focal Adhesion Protein-Tyrosine Kinases Proteins 0.000 description 1
• 108010008599 Forkhead Box Protein M1 Proteins 0.000 description 1
• 102100023374 Forkhead box protein M1 Human genes 0.000 description 1
• 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 1
• 102100037854 G1/S-specific cyclin-E2 Human genes 0.000 description 1
• 102100037488 G2 and S phase-expressed protein 1 Human genes 0.000 description 1
• 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 1
• 102100033201 G2/mitotic-specific cyclin-B2 Human genes 0.000 description 1
• 102100033452 GMP synthase [glutamine-hydrolyzing] Human genes 0.000 description 1
• 101710071060 GMPS Proteins 0.000 description 1
• 108700031843 GRB7 Adaptor Proteins 0.000 description 1
• 101150052409 GRB7 gene Proteins 0.000 description 1
• 102100030708 GTPase KRas Human genes 0.000 description 1
• 102100035212 Gamma-aminobutyric acid type B receptor subunit 1 Human genes 0.000 description 1
• 102100021023 Gamma-glutamyl hydrolase Human genes 0.000 description 1
• 102100040225 Gamma-interferon-inducible lysosomal thiol reductase Human genes 0.000 description 1
• 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
• 102100022624 Glucoamylase Human genes 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
• 108010024636 Glutathione Proteins 0.000 description 1
• 102100036528 Glutathione S-transferase Mu 3 Human genes 0.000 description 1
• 108010036164 Glutathione synthase Proteins 0.000 description 1
• 102100034294 Glutathione synthetase Human genes 0.000 description 1
• 102100040870 Glycine amidinotransferase, mitochondrial Human genes 0.000 description 1
• 241001148599 Gorgonidium Species 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 102100038367 Gremlin-1 Human genes 0.000 description 1
• 102100033107 Growth factor receptor-bound protein 7 Human genes 0.000 description 1
• 102100039874 Guanine nucleotide-binding protein G(z) subunit alpha Human genes 0.000 description 1
• 229940125497 HER2 kinase inhibitor Drugs 0.000 description 1
• 102100039171 Heat shock protein beta-2 Human genes 0.000 description 1
• 208000001258 Hemangiosarcoma Diseases 0.000 description 1
• 102100039389 Hepatoma-derived growth factor-related protein 3 Human genes 0.000 description 1
• 102100035617 Heterogeneous nuclear ribonucleoprotein A/B Human genes 0.000 description 1
• 102100028896 Heterogeneous nuclear ribonucleoprotein Q Human genes 0.000 description 1
• 102100022130 High mobility group protein B3 Human genes 0.000 description 1
• 102100029009 High mobility group protein HMG-I/HMG-Y Human genes 0.000 description 1
• 102100039236 Histone H3.3 Human genes 0.000 description 1
• 102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 102100022107 Holliday junction recognition protein Human genes 0.000 description 1
• 102100040615 Homeobox protein MSX-2 Human genes 0.000 description 1
• 102100032827 Homeodomain-interacting protein kinase 2 Human genes 0.000 description 1
• 101000964898 Homo sapiens 14-3-3 protein zeta/delta Proteins 0.000 description 1
• 101000590281 Homo sapiens 26S proteasome non-ATPase regulatory subunit 14 Proteins 0.000 description 1
• 101000590272 Homo sapiens 26S proteasome non-ATPase regulatory subunit 2 Proteins 0.000 description 1
• 101001035654 Homo sapiens 28 kDa heat- and acid-stable phosphoprotein Proteins 0.000 description 1
• 101000858474 Homo sapiens 28S ribosomal protein S6, mitochondrial Proteins 0.000 description 1
• 101000893701 Homo sapiens 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 Proteins 0.000 description 1
• 101000764864 Homo sapiens 3-hydroxybutyrate dehydrogenase type 2 Proteins 0.000 description 1
• 101000732165 Homo sapiens 40S ribosomal protein S4, X isoform Proteins 0.000 description 1
• 101000779641 Homo sapiens ALK tyrosine kinase receptor Proteins 0.000 description 1
• 101000757394 Homo sapiens AP-2 complex subunit alpha-2 Proteins 0.000 description 1
• 101000732341 Homo sapiens AP-2 complex subunit beta Proteins 0.000 description 1
• 101000924266 Homo sapiens AT-rich interactive domain-containing protein 1A Proteins 0.000 description 1
• 101000783770 Homo sapiens ATP-binding cassette sub-family D member 3 Proteins 0.000 description 1
• 101000887284 Homo sapiens ATPase family AAA domain-containing protein 2 Proteins 0.000 description 1
• 101000900939 Homo sapiens Abnormal spindle-like microcephaly-associated protein Proteins 0.000 description 1
• 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 1
• 101000798882 Homo sapiens Actin-like protein 6A Proteins 0.000 description 1
• 101000925566 Homo sapiens Actin-related protein 2/3 complex subunit 4 Proteins 0.000 description 1
• 101000848255 Homo sapiens Acyl-CoA 6-desaturase Proteins 0.000 description 1
• 101000959328 Homo sapiens Adenylate cyclase type 3 Proteins 0.000 description 1
• 101000775481 Homo sapiens Adenylate cyclase type 8 Proteins 0.000 description 1
• 101000959602 Homo sapiens Adhesion G-protein coupled receptor G6 Proteins 0.000 description 1
• 101000819490 Homo sapiens Alpha-(1,6)-fucosyltransferase Proteins 0.000 description 1
• 101000882335 Homo sapiens Alpha-enolase Proteins 0.000 description 1
• 101000833314 Homo sapiens Arf-GAP domain and FG repeat-containing protein 1 Proteins 0.000 description 1
• 101000884385 Homo sapiens Arylamine N-acetyltransferase 1 Proteins 0.000 description 1
• 101000798306 Homo sapiens Aurora kinase B Proteins 0.000 description 1
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
• 101000697681 Homo sapiens Basal body-orientation factor 1 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
• 101000777560 Homo sapiens CCN family member 4 Proteins 0.000 description 1
• 101000715674 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 2 Proteins 0.000 description 1
• 101000762242 Homo sapiens Cadherin-15 Proteins 0.000 description 1
• 101000714553 Homo sapiens Cadherin-3 Proteins 0.000 description 1
• 101000794587 Homo sapiens Cadherin-5 Proteins 0.000 description 1
• 101000737655 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 19 Proteins 0.000 description 1
• 101000933218 Homo sapiens Cathepsin F Proteins 0.000 description 1
• 101000983577 Homo sapiens Cathepsin L2 Proteins 0.000 description 1
• 101000980907 Homo sapiens Cell division cycle-associated protein 3 Proteins 0.000 description 1
• 101001099865 Homo sapiens Cellular retinoic acid-binding protein 1 Proteins 0.000 description 1
• 101000907941 Homo sapiens Centromere protein F Proteins 0.000 description 1
• 101000776412 Homo sapiens Centromere protein N Proteins 0.000 description 1
• 101000880512 Homo sapiens Centromere protein U Proteins 0.000 description 1
• 101000944476 Homo sapiens Centromere protein X Proteins 0.000 description 1
• 101000914247 Homo sapiens Centromere-associated protein E Proteins 0.000 description 1
• 101000741348 Homo sapiens Chromatin assembly factor 1 subunit A Proteins 0.000 description 1
• 101000944490 Homo sapiens Cilia- and flagella-associated protein 69 Proteins 0.000 description 1
• 101000765038 Homo sapiens Class E basic helix-loop-helix protein 40 Proteins 0.000 description 1
• 101000898006 Homo sapiens Cocaine esterase Proteins 0.000 description 1
• 101000771163 Homo sapiens Collagen alpha-1(II) chain Proteins 0.000 description 1
• 101000993285 Homo sapiens Collagen alpha-1(III) chain Proteins 0.000 description 1
• 101000710846 Homo sapiens Condensin complex subunit 1 Proteins 0.000 description 1
• 101000942617 Homo sapiens Condensin complex subunit 2 Proteins 0.000 description 1
• 101000749825 Homo sapiens Connector enhancer of kinase suppressor of ras 1 Proteins 0.000 description 1
• 101000934320 Homo sapiens Cyclin-A2 Proteins 0.000 description 1
• 101000980770 Homo sapiens Cyclin-C Proteins 0.000 description 1
• 101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
• 101000944357 Homo sapiens Cyclin-dependent kinase 16 Proteins 0.000 description 1
• 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 1
• 101000710200 Homo sapiens Cyclin-dependent kinases regulatory subunit 1 Proteins 0.000 description 1
• 101000942317 Homo sapiens Cyclin-dependent kinases regulatory subunit 2 Proteins 0.000 description 1
• 101000912205 Homo sapiens Cystatin-C Proteins 0.000 description 1
• 101000941723 Homo sapiens Cytochrome P450 2J2 Proteins 0.000 description 1
• 101000950656 Homo sapiens DEP domain-containing protein 1B Proteins 0.000 description 1
• 101000876529 Homo sapiens DNA excision repair protein ERCC-1 Proteins 0.000 description 1
• 101000909198 Homo sapiens DNA polymerase delta catalytic subunit Proteins 0.000 description 1
• 101001094659 Homo sapiens DNA polymerase kappa Proteins 0.000 description 1
• 101000865085 Homo sapiens DNA polymerase theta Proteins 0.000 description 1
• 101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 description 1
• 101000963174 Homo sapiens DNA replication licensing factor MCM3 Proteins 0.000 description 1
• 101000615280 Homo sapiens DNA replication licensing factor MCM4 Proteins 0.000 description 1
• 101001018484 Homo sapiens DNA replication licensing factor MCM6 Proteins 0.000 description 1
• 101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 description 1
• 101000801505 Homo sapiens DNA topoisomerase 2-alpha Proteins 0.000 description 1
• 101000655234 Homo sapiens DNA-binding protein SATB1 Proteins 0.000 description 1
• 101000755868 Homo sapiens Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Proteins 0.000 description 1
• 101000968287 Homo sapiens Denticleless protein homolog Proteins 0.000 description 1
• 101000793922 Homo sapiens Dipeptidyl peptidase 1 Proteins 0.000 description 1
• 101000870234 Homo sapiens DnaJ homolog subfamily C member 12 Proteins 0.000 description 1
• 101000584942 Homo sapiens Double-strand-break repair protein rad21 homolog Proteins 0.000 description 1
• 101001057621 Homo sapiens Dual specificity protein phosphatase 4 Proteins 0.000 description 1
• 101000908688 Homo sapiens Dynein light chain Tctex-type 1 Proteins 0.000 description 1
• 101000650316 Homo sapiens E3 ubiquitin-protein ligase RNF213 Proteins 0.000 description 1
• 101000841231 Homo sapiens Elongation factor 1-alpha 2 Proteins 0.000 description 1
• 101000925493 Homo sapiens Endothelin-1 Proteins 0.000 description 1
• 101001034811 Homo sapiens Eukaryotic translation initiation factor 4 gamma 2 Proteins 0.000 description 1
• 101000918311 Homo sapiens Exostosin-1 Proteins 0.000 description 1
• 101000854648 Homo sapiens Ezrin Proteins 0.000 description 1
• 101001062855 Homo sapiens Fatty acid-binding protein 5 Proteins 0.000 description 1
• 101001027674 Homo sapiens Fatty acid-binding protein, brain Proteins 0.000 description 1
• 101000738575 Homo sapiens G1/S-specific cyclin-E2 Proteins 0.000 description 1
• 101001026457 Homo sapiens G2 and S phase-expressed protein 1 Proteins 0.000 description 1
• 101000868643 Homo sapiens G2/mitotic-specific cyclin-B1 Proteins 0.000 description 1
• 101000713023 Homo sapiens G2/mitotic-specific cyclin-B2 Proteins 0.000 description 1
• 101000584612 Homo sapiens GTPase KRas Proteins 0.000 description 1
• 101001075374 Homo sapiens Gamma-glutamyl hydrolase Proteins 0.000 description 1
• 101001037132 Homo sapiens Gamma-interferon-inducible lysosomal thiol reductase Proteins 0.000 description 1
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
• 101001071716 Homo sapiens Glutathione S-transferase Mu 3 Proteins 0.000 description 1
• 101000893303 Homo sapiens Glycine amidinotransferase, mitochondrial Proteins 0.000 description 1
• 101001032872 Homo sapiens Gremlin-1 Proteins 0.000 description 1
• 101000887490 Homo sapiens Guanine nucleotide-binding protein G(z) subunit alpha Proteins 0.000 description 1
• 101000854036 Homo sapiens Heterogeneous nuclear ribonucleoprotein A/B Proteins 0.000 description 1
• 101000839069 Homo sapiens Heterogeneous nuclear ribonucleoprotein Q Proteins 0.000 description 1
• 101001045794 Homo sapiens High mobility group protein B3 Proteins 0.000 description 1
• 101000986380 Homo sapiens High mobility group protein HMG-I/HMG-Y Proteins 0.000 description 1
• 101001035966 Homo sapiens Histone H3.3 Proteins 0.000 description 1
• 101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 description 1
• 101001045907 Homo sapiens Holliday junction recognition protein Proteins 0.000 description 1
• 101000967222 Homo sapiens Homeobox protein MSX-2 Proteins 0.000 description 1
• 101001066401 Homo sapiens Homeodomain-interacting protein kinase 2 Proteins 0.000 description 1
• 101001081176 Homo sapiens Hyaluronan mediated motility receptor Proteins 0.000 description 1
• 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 description 1
• 101000913079 Homo sapiens IgG receptor FcRn large subunit p51 Proteins 0.000 description 1
• 101001003233 Homo sapiens Immediate early response gene 2 protein Proteins 0.000 description 1
• 101000975401 Homo sapiens Inositol 1,4,5-trisphosphate receptor type 3 Proteins 0.000 description 1
• 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 1
• 101001044940 Homo sapiens Insulin-like growth factor-binding protein 2 Proteins 0.000 description 1
• 101000840566 Homo sapiens Insulin-like growth factor-binding protein 5 Proteins 0.000 description 1
• 101001034844 Homo sapiens Interferon-induced transmembrane protein 1 Proteins 0.000 description 1
• 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 1
• 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
• 101001081533 Homo sapiens Isopentenyl-diphosphate Delta-isomerase 1 Proteins 0.000 description 1
• 101000998027 Homo sapiens Keratin, type I cytoskeletal 17 Proteins 0.000 description 1
• 101000998020 Homo sapiens Keratin, type I cytoskeletal 18 Proteins 0.000 description 1
• 101001056473 Homo sapiens Keratin, type II cytoskeletal 5 Proteins 0.000 description 1
• 101000605743 Homo sapiens Kinesin-like protein KIF23 Proteins 0.000 description 1
• 101001050567 Homo sapiens Kinesin-like protein KIF2C Proteins 0.000 description 1
• 101001006776 Homo sapiens Kinesin-like protein KIFC1 Proteins 0.000 description 1
• 101001021858 Homo sapiens Kynureninase Proteins 0.000 description 1
• 101001090713 Homo sapiens L-lactate dehydrogenase A chain Proteins 0.000 description 1
• 101000956778 Homo sapiens LETM1 domain-containing protein 1 Proteins 0.000 description 1
• 101001003581 Homo sapiens Lamin-B1 Proteins 0.000 description 1
• 101001039189 Homo sapiens Leucine-rich repeat-containing protein 17 Proteins 0.000 description 1
• 101000938676 Homo sapiens Liver carboxylesterase 1 Proteins 0.000 description 1
• 101001039207 Homo sapiens Low-density lipoprotein receptor-related protein 8 Proteins 0.000 description 1
• 101000946040 Homo sapiens Lysosomal-associated transmembrane protein 4B Proteins 0.000 description 1
• 101000624631 Homo sapiens M-phase inducer phosphatase 2 Proteins 0.000 description 1
• 101000990912 Homo sapiens Matrilysin Proteins 0.000 description 1
• 101000627851 Homo sapiens Matrix metalloproteinase-23 Proteins 0.000 description 1
• 101000956317 Homo sapiens Membrane-spanning 4-domains subfamily A member 4A Proteins 0.000 description 1
• 101001014567 Homo sapiens Membrane-spanning 4-domains subfamily A member 7 Proteins 0.000 description 1
• 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
• 101001014059 Homo sapiens Metallothionein-2 Proteins 0.000 description 1
• 101000962664 Homo sapiens Microtubule-associated protein RP/EB family member 1 Proteins 0.000 description 1
• 101000957756 Homo sapiens Microtubule-associated protein RP/EB family member 2 Proteins 0.000 description 1
• 101001018147 Homo sapiens Mitogen-activated protein kinase kinase kinase 4 Proteins 0.000 description 1
• 101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 1
• 101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 description 1
• 101000957259 Homo sapiens Mitotic spindle assembly checkpoint protein MAD2A Proteins 0.000 description 1
• 101000987094 Homo sapiens Moesin Proteins 0.000 description 1
• 101000590830 Homo sapiens Monocarboxylate transporter 1 Proteins 0.000 description 1
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
• 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 1
• 101000593405 Homo sapiens Myb-related protein B Proteins 0.000 description 1
• 101001112229 Homo sapiens Neutrophil cytosol factor 1 Proteins 0.000 description 1
• 101000973211 Homo sapiens Nuclear factor 1 B-type Proteins 0.000 description 1
• 101000991410 Homo sapiens Nucleolar and spindle-associated protein 1 Proteins 0.000 description 1
• 101000979629 Homo sapiens Nucleoside diphosphate kinase A Proteins 0.000 description 1
• 101000744394 Homo sapiens Oxidized purine nucleoside triphosphate hydrolase Proteins 0.000 description 1
• 101001098523 Homo sapiens PAX-interacting protein 1 Proteins 0.000 description 1
• 101001098930 Homo sapiens Pachytene checkpoint protein 2 homolog Proteins 0.000 description 1
• 101001060744 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP1A Proteins 0.000 description 1
• 101000579342 Homo sapiens Peroxisome assembly protein 12 Proteins 0.000 description 1
• 101001102158 Homo sapiens Phosphatidylserine synthase 1 Proteins 0.000 description 1
• 101000600387 Homo sapiens Phosphoglycerate mutase 1 Proteins 0.000 description 1
• 101000595918 Homo sapiens Phospholipase A and acyltransferase 4 Proteins 0.000 description 1
• 101000745252 Homo sapiens Plasma membrane ascorbate-dependent reductase CYBRD1 Proteins 0.000 description 1
• 101000613207 Homo sapiens Pre-B-cell leukemia transcription factor-interacting protein 1 Proteins 0.000 description 1
• 101000690940 Homo sapiens Pro-adrenomedullin Proteins 0.000 description 1
• 101000702559 Homo sapiens Probable global transcription activator SNF2L2 Proteins 0.000 description 1
• 101000600395 Homo sapiens Probable phosphoglycerate mutase 4 Proteins 0.000 description 1
• 101000983583 Homo sapiens Procathepsin L Proteins 0.000 description 1
• 101000595904 Homo sapiens Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 Proteins 0.000 description 1
• 101001123448 Homo sapiens Prolactin receptor Proteins 0.000 description 1
• 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 description 1
• 101001091094 Homo sapiens Prorelaxin H1 Proteins 0.000 description 1
• 101001136954 Homo sapiens Proteasome subunit beta type-7 Proteins 0.000 description 1
• 101000817237 Homo sapiens Protein ECT2 Proteins 0.000 description 1
• 101001065541 Homo sapiens Protein LYRIC Proteins 0.000 description 1
• 101001074602 Homo sapiens Protein PIMREG Proteins 0.000 description 1
• 101000880769 Homo sapiens Protein SSX1 Proteins 0.000 description 1
• 101000880774 Homo sapiens Protein SSX4 Proteins 0.000 description 1
• 101000880775 Homo sapiens Protein SSX5 Proteins 0.000 description 1
• 101000819227 Homo sapiens Protein YIF1A Proteins 0.000 description 1
• 101000780643 Homo sapiens Protein argonaute-2 Proteins 0.000 description 1
• 101000928406 Homo sapiens Protein diaphanous homolog 3 Proteins 0.000 description 1
• 101001098824 Homo sapiens Protein disulfide-isomerase A4 Proteins 0.000 description 1
• 101000931680 Homo sapiens Protein furry homolog Proteins 0.000 description 1
• 101001000061 Homo sapiens Protein phosphatase 1 regulatory subunit 12A Proteins 0.000 description 1
• 101000738322 Homo sapiens Prothymosin alpha Proteins 0.000 description 1
• 101001096541 Homo sapiens Rac GTPase-activating protein 1 Proteins 0.000 description 1
• 101000694802 Homo sapiens Receptor-type tyrosine-protein phosphatase T Proteins 0.000 description 1
• 101001099922 Homo sapiens Retinoic acid-induced protein 1 Proteins 0.000 description 1
• 101000581118 Homo sapiens Rho-related GTP-binding protein RhoC Proteins 0.000 description 1
• 101000692933 Homo sapiens Ribonuclease 4 Proteins 0.000 description 1
• 101001103771 Homo sapiens Ribonuclease H2 subunit A Proteins 0.000 description 1
• 101000575639 Homo sapiens Ribonucleoside-diphosphate reductase subunit M2 Proteins 0.000 description 1
• 101001093937 Homo sapiens SEC14-like protein 1 Proteins 0.000 description 1
• 101000687718 Homo sapiens SWI/SNF complex subunit SMARCC1 Proteins 0.000 description 1
• 101000687720 Homo sapiens SWI/SNF complex subunit SMARCC2 Proteins 0.000 description 1
• 101000687737 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 Proteins 0.000 description 1
• 101000702542 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 Proteins 0.000 description 1
• 101000864793 Homo sapiens Secreted frizzled-related protein 4 Proteins 0.000 description 1
• 101001087372 Homo sapiens Securin Proteins 0.000 description 1
• 101000700735 Homo sapiens Serine/arginine-rich splicing factor 7 Proteins 0.000 description 1
• 101000628647 Homo sapiens Serine/threonine-protein kinase 24 Proteins 0.000 description 1
• 101000880439 Homo sapiens Serine/threonine-protein kinase 3 Proteins 0.000 description 1
• 101000576901 Homo sapiens Serine/threonine-protein kinase MRCK alpha Proteins 0.000 description 1
• 101000783373 Homo sapiens Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform Proteins 0.000 description 1
• 101000836394 Homo sapiens Sestrin-1 Proteins 0.000 description 1
• 101000929936 Homo sapiens Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 1
• 101000631713 Homo sapiens Signal peptide, CUB and EGF-like domain-containing protein 2 Proteins 0.000 description 1
• 101000657845 Homo sapiens Small nuclear ribonucleoprotein-associated proteins B and B' Proteins 0.000 description 1
• 101000639975 Homo sapiens Sodium-dependent noradrenaline transporter Proteins 0.000 description 1
• 101000713288 Homo sapiens Solute carrier family 22 member 5 Proteins 0.000 description 1
• 101000881206 Homo sapiens Spermine synthase Proteins 0.000 description 1
• 101000633700 Homo sapiens Src kinase-associated phosphoprotein 1 Proteins 0.000 description 1
• 101000831940 Homo sapiens Stathmin Proteins 0.000 description 1
• 101000631826 Homo sapiens Stearoyl-CoA desaturase Proteins 0.000 description 1
• 101000825726 Homo sapiens Structural maintenance of chromosomes protein 4 Proteins 0.000 description 1
• 101000716763 Homo sapiens Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Proteins 0.000 description 1
• 101001131276 Homo sapiens Sulfhydryl oxidase 2 Proteins 0.000 description 1
• 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 description 1
• 101000713596 Homo sapiens T-box transcription factor TBX19 Proteins 0.000 description 1
• 101000653663 Homo sapiens T-complex protein 1 subunit epsilon Proteins 0.000 description 1
• 101000713879 Homo sapiens T-complex protein 1 subunit eta Proteins 0.000 description 1
• 101000653469 Homo sapiens T-complex protein 1 subunit zeta Proteins 0.000 description 1
• 101000652662 Homo sapiens Taste receptor type 2 member 5 Proteins 0.000 description 1
• 101000794194 Homo sapiens Tetraspanin-1 Proteins 0.000 description 1
• 101000612994 Homo sapiens Tetraspanin-4 Proteins 0.000 description 1
• 101000844686 Homo sapiens Thioredoxin reductase 1, cytoplasmic Proteins 0.000 description 1
• 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 1
• 101000702545 Homo sapiens Transcription activator BRG1 Proteins 0.000 description 1
• 101000666385 Homo sapiens Transcription factor Dp-2 Proteins 0.000 description 1
• 101000658563 Homo sapiens Transcription initiation factor IIE subunit beta Proteins 0.000 description 1
• 101000802109 Homo sapiens Transducin-like enhancer protein 3 Proteins 0.000 description 1
• 101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
• 101000836148 Homo sapiens Transforming acidic coiled-coil-containing protein 2 Proteins 0.000 description 1
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 1
• 101000831866 Homo sapiens Transmembrane protein 45A Proteins 0.000 description 1
• 101000838463 Homo sapiens Tubulin alpha-1A chain Proteins 0.000 description 1
• 101000625727 Homo sapiens Tubulin beta chain Proteins 0.000 description 1
• 101000788517 Homo sapiens Tubulin beta-2A chain Proteins 0.000 description 1
• 101000838301 Homo sapiens Tubulin gamma-1 chain Proteins 0.000 description 1
• 101000750285 Homo sapiens Tubulinyl-Tyr carboxypeptidase 1 Proteins 0.000 description 1
• 101000830568 Homo sapiens Tumor necrosis factor alpha-induced protein 2 Proteins 0.000 description 1
• 101000836174 Homo sapiens Tumor protein p53-inducible nuclear protein 1 Proteins 0.000 description 1
• 101000639792 Homo sapiens U2 small nuclear ribonucleoprotein A' Proteins 0.000 description 1
• 101000807354 Homo sapiens Ubiquitin-conjugating enzyme E2 C Proteins 0.000 description 1
• 101000837565 Homo sapiens Ubiquitin-conjugating enzyme E2 S Proteins 0.000 description 1
• 101000760337 Homo sapiens Urokinase plasminogen activator surface receptor Proteins 0.000 description 1
• 101000871915 Homo sapiens Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 Proteins 0.000 description 1
• 101000955067 Homo sapiens WAP four-disulfide core domain protein 2 Proteins 0.000 description 1
• 101000788741 Homo sapiens Zinc finger MYM-type protein 4 Proteins 0.000 description 1
• 101000760180 Homo sapiens Zinc finger protein 43 Proteins 0.000 description 1
• 101150081092 Hspb2 gene Proteins 0.000 description 1
• 102100027735 Hyaluronan mediated motility receptor Human genes 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 1
• 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 1
• 102100020702 Immediate early response gene 2 protein Human genes 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102100024035 Inositol 1,4,5-trisphosphate receptor type 3 Human genes 0.000 description 1
• 102100023915 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102100036721 Insulin receptor Human genes 0.000 description 1
• 102100022710 Insulin-like growth factor-binding protein 2 Human genes 0.000 description 1
• 102100029225 Insulin-like growth factor-binding protein 5 Human genes 0.000 description 1
• 102100040021 Interferon-induced transmembrane protein 1 Human genes 0.000 description 1
• 102100033501 Interleukin-32 Human genes 0.000 description 1
• 102100027665 Isopentenyl-diphosphate Delta-isomerase 1 Human genes 0.000 description 1
• 206010069755 K-ras gene mutation Diseases 0.000 description 1
• 102100034872 Kallikrein-4 Human genes 0.000 description 1
• 102100033511 Keratin, type I cytoskeletal 17 Human genes 0.000 description 1
• 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 description 1
• 102100025756 Keratin, type II cytoskeletal 5 Human genes 0.000 description 1
• 102100023972 Keratin, type II cytoskeletal 8 Human genes 0.000 description 1
• 108010070511 Keratin-8 Proteins 0.000 description 1
• 102100038406 Kinesin-like protein KIF23 Human genes 0.000 description 1
• 102100023424 Kinesin-like protein KIF2C Human genes 0.000 description 1
• 102100027942 Kinesin-like protein KIFC1 Human genes 0.000 description 1
• 102100036091 Kynureninase Human genes 0.000 description 1
• MLFKVJCWGUZWNV-UHFFFAOYSA-N L-alanosine Natural products OC(=O)C(N)CN(O)N=O MLFKVJCWGUZWNV-UHFFFAOYSA-N 0.000 description 1
• 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
• 102100034671 L-lactate dehydrogenase A chain Human genes 0.000 description 1
• 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• 239000005517 L01XE01 - Imatinib Substances 0.000 description 1
• 239000005411 L01XE02 - Gefitinib Substances 0.000 description 1
• 239000002147 L01XE04 - Sunitinib Substances 0.000 description 1
• 239000002136 L01XE07 - Lapatinib Substances 0.000 description 1
• 102100038448 LETM1 domain-containing protein 1 Human genes 0.000 description 1
• 102100026517 Lamin-B1 Human genes 0.000 description 1
• 102000052922 Large Neutral Amino Acid-Transporter 1 Human genes 0.000 description 1
• 102100040690 Leucine-rich repeat-containing protein 17 Human genes 0.000 description 1
• 108010000817 Leuprolide Proteins 0.000 description 1
• 239000012097 Lipofectamine 2000 Substances 0.000 description 1
• 102100040705 Low-density lipoprotein receptor-related protein 8 Human genes 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 206010050017 Lung cancer metastatic Diseases 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 102100034726 Lysosomal-associated transmembrane protein 4B Human genes 0.000 description 1
• 102100023325 M-phase inducer phosphatase 2 Human genes 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 238000000585 Mann–Whitney U test Methods 0.000 description 1
• 102100024299 Maternal embryonic leucine zipper kinase Human genes 0.000 description 1
• 101710154611 Maternal embryonic leucine zipper kinase Proteins 0.000 description 1
• 102100030417 Matrilysin Human genes 0.000 description 1
• 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
• 102100024130 Matrix metalloproteinase-23 Human genes 0.000 description 1
• 102100032512 Membrane-spanning 4-domains subfamily A member 7 Human genes 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
• 102100031347 Metallothionein-2 Human genes 0.000 description 1
• 206010050513 Metastatic renal cell carcinoma Diseases 0.000 description 1
• 229940122255 Microtubule inhibitor Drugs 0.000 description 1
• 102100039560 Microtubule-associated protein RP/EB family member 1 Human genes 0.000 description 1
• 102100038615 Microtubule-associated protein RP/EB family member 2 Human genes 0.000 description 1
• 102100033060 Mitogen-activated protein kinase kinase kinase 4 Human genes 0.000 description 1
• 102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 1
• 102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 description 1
• 102100038792 Mitotic spindle assembly checkpoint protein MAD2A Human genes 0.000 description 1
• 102100027869 Moesin Human genes 0.000 description 1
• 102100034068 Monocarboxylate transporter 1 Human genes 0.000 description 1
• 102100034256 Mucin-1 Human genes 0.000 description 1
• 102100023123 Mucin-16 Human genes 0.000 description 1
• 101100366245 Mus musculus Supt16h gene Proteins 0.000 description 1
• 102100034670 Myb-related protein B Human genes 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 208000005927 Myosarcoma Diseases 0.000 description 1
• PCNLLVFKBKMRDB-UHFFFAOYSA-N N-ethyl-N-[[2-(1-pentylindol-3-yl)-1,3-thiazol-4-yl]methyl]ethanamine Chemical compound C(C)N(CC=1N=C(SC=1)C1=CN(C2=CC=CC=C12)CCCCC)CC PCNLLVFKBKMRDB-UHFFFAOYSA-N 0.000 description 1
• 108700019961 Neoplasm Genes Proteins 0.000 description 1
• 102000048850 Neoplasm Genes Human genes 0.000 description 1
• 102100038878 Neuropeptide Y receptor type 1 Human genes 0.000 description 1
• 102100023620 Neutrophil cytosol factor 1 Human genes 0.000 description 1
• 108010088865 Nicotinamide N-Methyltransferase Proteins 0.000 description 1
• 102000009063 Nicotinamide N-methyltransferase Human genes 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 102100022165 Nuclear factor 1 B-type Human genes 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 102100030991 Nucleolar and spindle-associated protein 1 Human genes 0.000 description 1
• 108010025568 Nucleophosmin Proteins 0.000 description 1
• 102100023252 Nucleoside diphosphate kinase A Human genes 0.000 description 1
• 108010047956 Nucleosomes Proteins 0.000 description 1
• 108010016076 Octreotide Proteins 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 102100026747 Osteomodulin Human genes 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 102100039792 Oxidized purine nucleoside triphosphate hydrolase Human genes 0.000 description 1
• 102100037141 PAX-interacting protein 1 Human genes 0.000 description 1
• 102000038030 PI3Ks Human genes 0.000 description 1
• 108091007960 PI3Ks Proteins 0.000 description 1
• 101150038998 PLAUR gene Proteins 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 102100038993 Pachytene checkpoint protein 2 homolog Human genes 0.000 description 1
• 241000282577 Pan troglodytes Species 0.000 description 1
• 208000008900 Pancreatic Ductal Carcinoma Diseases 0.000 description 1
• 241001504519 Papio ursinus Species 0.000 description 1
• 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 1
• 102000007456 Peroxiredoxin Human genes 0.000 description 1
• 102100028224 Peroxisome assembly protein 12 Human genes 0.000 description 1
• 241000009328 Perro Species 0.000 description 1
• 102100039298 Phosphatidylserine synthase 1 Human genes 0.000 description 1
• 102100037389 Phosphoglycerate mutase 1 Human genes 0.000 description 1
• 102100035200 Phospholipase A and acyltransferase 4 Human genes 0.000 description 1
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
• 102100039902 Plasma membrane ascorbate-dependent reductase CYBRD1 Human genes 0.000 description 1
• 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 description 1
• 108010000598 Polycomb Repressive Complex 1 Proteins 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 102100040882 Pre-B-cell leukemia transcription factor-interacting protein 1 Human genes 0.000 description 1
• 102100026651 Pro-adrenomedullin Human genes 0.000 description 1
• 101710145525 Probable cinnamyl alcohol dehydrogenase Proteins 0.000 description 1
• 102100031021 Probable global transcription activator SNF2L2 Human genes 0.000 description 1
• 102100026534 Procathepsin L Human genes 0.000 description 1
• 102100035202 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 Human genes 0.000 description 1
• 102100029000 Prolactin receptor Human genes 0.000 description 1
• 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 1
• 102100034945 Prorelaxin H1 Human genes 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 102100031300 Proteasome activator complex subunit 1 Human genes 0.000 description 1
• 101710103872 Proteasome activator complex subunit 1 Proteins 0.000 description 1
• 102100035763 Proteasome subunit beta type-7 Human genes 0.000 description 1
• 102100040437 Protein ECT2 Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 102100032133 Protein LYRIC Human genes 0.000 description 1
• 102100036258 Protein PIMREG Human genes 0.000 description 1
• 102100032442 Protein S100-A8 Human genes 0.000 description 1
• 102100037687 Protein SSX1 Human genes 0.000 description 1
• 102100037686 Protein SSX2 Human genes 0.000 description 1
• 102100037727 Protein SSX4 Human genes 0.000 description 1
• 102100037723 Protein SSX5 Human genes 0.000 description 1
• 108010001267 Protein Subunits Proteins 0.000 description 1
• 102000002067 Protein Subunits Human genes 0.000 description 1
• 102100021294 Protein YIF1A Human genes 0.000 description 1
• 102100034207 Protein argonaute-2 Human genes 0.000 description 1
• 102100036468 Protein diaphanous homolog 3 Human genes 0.000 description 1
• 102100037089 Protein disulfide-isomerase A4 Human genes 0.000 description 1
• 102100020918 Protein furry homolog Human genes 0.000 description 1
• 102100036547 Protein phosphatase 1 regulatory subunit 12A Human genes 0.000 description 1
• 102100033947 Protein regulator of cytokinesis 1 Human genes 0.000 description 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102100037925 Prothymosin alpha Human genes 0.000 description 1
• XESARGFCSKSFID-UHFFFAOYSA-N Pyrazofurin Natural products OC1=C(C(=O)N)NN=C1C1C(O)C(O)C(CO)O1 XESARGFCSKSFID-UHFFFAOYSA-N 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 238000003559 RNA-seq method Methods 0.000 description 1
• 102100037414 Rac GTPase-activating protein 1 Human genes 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 101710100969 Receptor tyrosine-protein kinase erbB-3 Proteins 0.000 description 1
• 102100029986 Receptor tyrosine-protein kinase erbB-3 Human genes 0.000 description 1
• 102100028645 Receptor-type tyrosine-protein phosphatase T Human genes 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 206010038111 Recurrent cancer Diseases 0.000 description 1
• 102100027610 Rho-related GTP-binding protein RhoC Human genes 0.000 description 1
• 102100026411 Ribonuclease 4 Human genes 0.000 description 1
• 102100039493 Ribonuclease H2 subunit A Human genes 0.000 description 1
• 102100026006 Ribonucleoside-diphosphate reductase subunit M2 Human genes 0.000 description 1
• 230000018199 S phase Effects 0.000 description 1
• 102100035214 SEC14-like protein 1 Human genes 0.000 description 1
• 108091006703 SLC25A1 Proteins 0.000 description 1
• 108091006715 SLC25A5 Proteins 0.000 description 1
• 102000037053 SLC35 Human genes 0.000 description 1
• 108091006185 SLC35 Proteins 0.000 description 1
• 108091006938 SLC39A6 Proteins 0.000 description 1
• 108091006313 SLC3A2 Proteins 0.000 description 1
• 108091006232 SLC7A5 Proteins 0.000 description 1
• 108700028341 SMARCB1 Proteins 0.000 description 1
• 101150008214 SMARCB1 gene Proteins 0.000 description 1
• 102000008935 SMN Complex Proteins Human genes 0.000 description 1
• 108010049037 SMN Complex Proteins Proteins 0.000 description 1
• 102100024793 SWI/SNF complex subunit SMARCC1 Human genes 0.000 description 1
• 102100024790 SWI/SNF complex subunit SMARCC2 Human genes 0.000 description 1
• 102100025746 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 Human genes 0.000 description 1
• 102100024777 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 Human genes 0.000 description 1
• 102100031029 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 Human genes 0.000 description 1
• 101100127690 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA2 gene Proteins 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 101100010298 Schizosaccharomyces pombe (strain 972 / ATCC 24843) pol2 gene Proteins 0.000 description 1
• 102100030052 Secreted frizzled-related protein 4 Human genes 0.000 description 1
• 108091058545 Secretory proteins Proteins 0.000 description 1
• 102000040739 Secretory proteins Human genes 0.000 description 1
• 102100033004 Securin Human genes 0.000 description 1
• 102100029287 Serine/arginine-rich splicing factor 7 Human genes 0.000 description 1
• 101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
• 102100026764 Serine/threonine-protein kinase 24 Human genes 0.000 description 1
• 102100025352 Serine/threonine-protein kinase MRCK alpha Human genes 0.000 description 1
• 102100031463 Serine/threonine-protein kinase PLK1 Human genes 0.000 description 1
• 102100036140 Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform Human genes 0.000 description 1
• 102100027288 Sestrin-1 Human genes 0.000 description 1
• 102100035766 Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
• 102100028932 Signal peptide, CUB and EGF-like domain-containing protein 2 Human genes 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• 102100034683 Small nuclear ribonucleoprotein-associated proteins B and B' Human genes 0.000 description 1
• 102100033929 Sodium-dependent noradrenaline transporter Human genes 0.000 description 1
• 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
• 102100037616 Spermine synthase Human genes 0.000 description 1
• 102100029208 Src kinase-associated phosphoprotein 1 Human genes 0.000 description 1
• 102100024237 Stathmin Human genes 0.000 description 1
• 102100028897 Stearoyl-CoA desaturase Human genes 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 102100022842 Structural maintenance of chromosomes protein 4 Human genes 0.000 description 1
• 102100020868 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Human genes 0.000 description 1
• 102100034359 Sulfhydryl oxidase 2 Human genes 0.000 description 1
• 102000019197 Superoxide Dismutase Human genes 0.000 description 1
• 108010012715 Superoxide dismutase Proteins 0.000 description 1
• 108010002687 Survivin Proteins 0.000 description 1
• 241000282898 Sus scrofa Species 0.000 description 1
• 102100035721 Syndecan-1 Human genes 0.000 description 1
• 102100036773 T-box transcription factor TBX19 Human genes 0.000 description 1
• 102100029886 T-complex protein 1 subunit epsilon Human genes 0.000 description 1
• 102100036476 T-complex protein 1 subunit eta Human genes 0.000 description 1
• 102100030664 T-complex protein 1 subunit zeta Human genes 0.000 description 1
• 102100030827 Taste receptor type 2 member 5 Human genes 0.000 description 1
• 229940123237 Taxane Drugs 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 102100030169 Tetraspanin-1 Human genes 0.000 description 1
• 102100040871 Tetraspanin-4 Human genes 0.000 description 1
• 101000874827 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) Dephospho-CoA kinase Proteins 0.000 description 1
• 102100031208 Thioredoxin reductase 1, cytoplasmic Human genes 0.000 description 1
• FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical compound C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 description 1
• 102100033504 Thyroglobulin Human genes 0.000 description 1
• 108010034949 Thyroglobulin Proteins 0.000 description 1
• 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 1
• 102100031027 Transcription activator BRG1 Human genes 0.000 description 1
• 102100038312 Transcription factor Dp-2 Human genes 0.000 description 1
• 102100034904 Transcription initiation factor IIE subunit beta Human genes 0.000 description 1
• 102100034698 Transducin-like enhancer protein 3 Human genes 0.000 description 1
• 102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
• 102100027044 Transforming acidic coiled-coil-containing protein 2 Human genes 0.000 description 1
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 1
• 102100024186 Transmembrane protein 45A Human genes 0.000 description 1
• 206010066901 Treatment failure Diseases 0.000 description 1
• 108010078184 Trefoil Factor-3 Proteins 0.000 description 1
• 102100039145 Trefoil factor 3 Human genes 0.000 description 1
• 102100036216 Tricarboxylate transport protein, mitochondrial Human genes 0.000 description 1
• OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
• 102000004243 Tubulin Human genes 0.000 description 1
• 108090000704 Tubulin Proteins 0.000 description 1
• 102100028968 Tubulin alpha-1A chain Human genes 0.000 description 1
• 102100024717 Tubulin beta chain Human genes 0.000 description 1
• 102100028979 Tubulin gamma-1 chain Human genes 0.000 description 1
• 102100021163 Tubulinyl-Tyr carboxypeptidase 1 Human genes 0.000 description 1
• 108010078814 Tumor Suppressor Protein p53 Proteins 0.000 description 1
• 102100024595 Tumor necrosis factor alpha-induced protein 2 Human genes 0.000 description 1
• 102100027224 Tumor protein p53-inducible nuclear protein 1 Human genes 0.000 description 1
• 102100034465 U2 small nuclear ribonucleoprotein A' Human genes 0.000 description 1
• 108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 1
• 102100025038 Ubiquitin carboxyl-terminal hydrolase isozyme L1 Human genes 0.000 description 1
• 102100037256 Ubiquitin-conjugating enzyme E2 C Human genes 0.000 description 1
• 102100028718 Ubiquitin-conjugating enzyme E2 S Human genes 0.000 description 1
• 102100031590 Uncharacterized protein encoded by LINC01587 Human genes 0.000 description 1
• 208000034940 Undiagnosed disease Diseases 0.000 description 1
• 102100024689 Urokinase plasminogen activator surface receptor Human genes 0.000 description 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
• 102100033576 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 Human genes 0.000 description 1
• 102100035071 Vimentin Human genes 0.000 description 1
• 108010065472 Vimentin Proteins 0.000 description 1
• 229940122803 Vinca alkaloid Drugs 0.000 description 1
• 102100038965 WAP four-disulfide core domain protein 2 Human genes 0.000 description 1
• 235000010724 Wisteria floribunda Nutrition 0.000 description 1
• 108091002437 YBX1 Proteins 0.000 description 1
• 102000033021 YBX1 Human genes 0.000 description 1
• 102100025418 Zinc finger MYM-type protein 4 Human genes 0.000 description 1
• 102100024666 Zinc finger protein 43 Human genes 0.000 description 1
• 102100023144 Zinc transporter ZIP6 Human genes 0.000 description 1
• ZPCCSZFPOXBNDL-ZSTSFXQOSA-N [(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoe Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]([C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)OC(C)=O)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 ZPCCSZFPOXBNDL-ZSTSFXQOSA-N 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 229940022698 acetylcholinesterase Drugs 0.000 description 1
• QAWIHIJWNYOLBE-OKKQSCSOSA-N acivicin Chemical compound OC(=O)[C@@H](N)[C@@H]1CC(Cl)=NO1 QAWIHIJWNYOLBE-OKKQSCSOSA-N 0.000 description 1
• 229950008427 acivicin Drugs 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-O acridine;hydron Chemical compound C1=CC=CC2=CC3=CC=CC=C3[NH+]=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-O 0.000 description 1
• 229930183665 actinomycin Natural products 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 229940009456 adriamycin Drugs 0.000 description 1
• 229950005033 alanosine Drugs 0.000 description 1
• 229940100198 alkylating agent Drugs 0.000 description 1
• 239000002168 alkylating agent Substances 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 238000010171 animal model Methods 0.000 description 1
• 230000002942 anti-growth Effects 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000003886 aromatase inhibitor Substances 0.000 description 1
• 229960003272 asparaginase Drugs 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
• 230000017047 asymmetric cell division Effects 0.000 description 1
• 229940120638 avastin Drugs 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 238000002725 brachytherapy Methods 0.000 description 1
• 229960002092 busulfan Drugs 0.000 description 1
• 238000010805 cDNA synthesis kit Methods 0.000 description 1
• 229960004015 calcitonin Drugs 0.000 description 1
• BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
• VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
• 229940127093 camptothecin Drugs 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• 230000000711 cancerogenic effect Effects 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 150000001716 carbazoles Chemical class 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 231100000315 carcinogenic Toxicity 0.000 description 1
• 239000003183 carcinogenic agent Substances 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 239000002771 cell marker Substances 0.000 description 1
• 239000013553 cell monolayer Substances 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 229960005395 cetuximab Drugs 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 230000005929 chemotherapeutic response Effects 0.000 description 1
• 238000009104 chemotherapy regimen Methods 0.000 description 1
• 229960004630 chlorambucil Drugs 0.000 description 1
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
• 229940015047 chorionic gonadotropin Drugs 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 229960002436 cladribine Drugs 0.000 description 1
• 230000003081 coactivator Effects 0.000 description 1
• 230000005757 colony formation Effects 0.000 description 1
• 230000001332 colony forming effect Effects 0.000 description 1
• 239000003086 colorant Substances 0.000 description 1
• 238000009096 combination chemotherapy Methods 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 238000004891 communication Methods 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 239000013068 control sample Substances 0.000 description 1
• 238000011443 conventional therapy Methods 0.000 description 1
• 239000013256 coordination polymer Substances 0.000 description 1
• 230000001186 cumulative effect Effects 0.000 description 1
• 229960000684 cytarabine Drugs 0.000 description 1
• 230000002559 cytogenic effect Effects 0.000 description 1
• 229960003901 dacarbazine Drugs 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000013480 data collection Methods 0.000 description 1
• 238000013079 data visualisation Methods 0.000 description 1
• 229960000975 daunorubicin Drugs 0.000 description 1
• STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
• 229950008937 defactinib Drugs 0.000 description 1
• 229950007998 demcizumab Drugs 0.000 description 1
• CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 108020001096 dihydrofolate reductase Proteins 0.000 description 1
• BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
• VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
• 239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
• ZWAOHEXOSAUJHY-ZIYNGMLESA-N doxifluridine Chemical compound O[C@@H]1[C@H](O)[C@@H](C)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ZWAOHEXOSAUJHY-ZIYNGMLESA-N 0.000 description 1
• 229940079593 drug Drugs 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 229940121647 egfr inhibitor Drugs 0.000 description 1
• 238000001983 electron spin resonance imaging Methods 0.000 description 1
• 201000003908 endometrial adenocarcinoma Diseases 0.000 description 1
• 208000028730 endometrioid adenocarcinoma Diseases 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• 229940082789 erbitux Drugs 0.000 description 1
• 229960001433 erlotinib Drugs 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 229960005420 etoposide Drugs 0.000 description 1
• VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 238000010195 expression analysis Methods 0.000 description 1
• 238000011347 external beam therapy Methods 0.000 description 1
• 239000004744 fabric Substances 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• VLMZMRDOMOGGFA-WDBKCZKBSA-N festuclavine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C)=C3C2=CNC3=C1 VLMZMRDOMOGGFA-WDBKCZKBSA-N 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 229950003499 fibrin Drugs 0.000 description 1
• 229940012952 fibrinogen Drugs 0.000 description 1
• ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 1
• 229960000390 fludarabine Drugs 0.000 description 1
• GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
• 238000001917 fluorescence detection Methods 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
• 229960002074 flutamide Drugs 0.000 description 1
• VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 1
• 235000008191 folinic acid Nutrition 0.000 description 1
• 239000011672 folinic acid Substances 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 229960002584 gefitinib Drugs 0.000 description 1
• XGALLCVXEZPNRQ-UHFFFAOYSA-N gefitinib Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=NC=1NC1=CC=C(F)C(Cl)=C1 XGALLCVXEZPNRQ-UHFFFAOYSA-N 0.000 description 1
• 230000000762 glandular Effects 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 229960002913 goserelin Drugs 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 102000018511 hepcidin Human genes 0.000 description 1
• 108060003558 hepcidin Proteins 0.000 description 1
• 229940022353 herceptin Drugs 0.000 description 1
• 238000012165 high-throughput sequencing Methods 0.000 description 1
• 102000050021 human SSRP1 Human genes 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 229960000890 hydrocortisone Drugs 0.000 description 1
• 230000001146 hypoxic effect Effects 0.000 description 1
• 238000005286 illumination Methods 0.000 description 1
• KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 1
• 229960002411 imatinib Drugs 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 230000000984 immunochemical effect Effects 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000007901 in situ hybridization Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 210000004283 incisor Anatomy 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 239000000138 intercalating agent Substances 0.000 description 1
• 230000000968 intestinal effect Effects 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 229960004768 irinotecan Drugs 0.000 description 1
• 229960000779 irinotecan hydrochloride Drugs 0.000 description 1
• 108010024383 kallikrein 4 Proteins 0.000 description 1
• 229960004125 ketoconazole Drugs 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 238000011813 knockout mouse model Methods 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 229960004891 lapatinib Drugs 0.000 description 1
• BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 description 1
• 229960001691 leucovorin Drugs 0.000 description 1
• GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
• 229960004338 leuprorelin Drugs 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
• 201000005249 lung adenocarcinoma Diseases 0.000 description 1
• 238000007403 mPCR Methods 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 229960004961 mechlorethamine Drugs 0.000 description 1
• HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical class ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 229960001924 melphalan Drugs 0.000 description 1
• SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 description 1
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 1
• 229960001428 mercaptopurine Drugs 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
• 229960003105 metformin Drugs 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 231100000782 microtubule inhibitor Toxicity 0.000 description 1
• CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
• 230000011278 mitosis Effects 0.000 description 1
• 229960001156 mitoxantrone Drugs 0.000 description 1
• KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 1
• 201000010879 mucinous adenocarcinoma Diseases 0.000 description 1
• 201000002077 muscle cancer Diseases 0.000 description 1
• ZTLGJPIZUOVDMT-UHFFFAOYSA-N n,n-dichlorotriazin-4-amine Chemical compound ClN(Cl)C1=CC=NN=N1 ZTLGJPIZUOVDMT-UHFFFAOYSA-N 0.000 description 1
• RUUPNXCMBFXOSI-UHFFFAOYSA-N n-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxybutanamide Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)C(C)C(O)C(=O)NC1=CC=C(C#N)C(C(F)(F)F)=C1 RUUPNXCMBFXOSI-UHFFFAOYSA-N 0.000 description 1
• DPHUWDIXHNQOSY-UHFFFAOYSA-N napabucasin Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1OC(C(=O)C)=C2 DPHUWDIXHNQOSY-UHFFFAOYSA-N 0.000 description 1
• 108010043412 neuropeptide Y-Y1 receptor Proteins 0.000 description 1
• 238000010606 normalization Methods 0.000 description 1
• 238000009206 nuclear medicine Methods 0.000 description 1
• 238000012758 nuclear staining Methods 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 238000007826 nucleic acid assay Methods 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 210000001623 nucleosome Anatomy 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 201000008968 osteosarcoma Diseases 0.000 description 1
• 230000002611 ovarian Effects 0.000 description 1
• 150000003901 oxalic acid esters Chemical class 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 229960001972 panitumumab Drugs 0.000 description 1
• 201000010279 papillary renal cell carcinoma Diseases 0.000 description 1
• 239000013610 patient sample Substances 0.000 description 1
• FPVKHBSQESCIEP-JQCXWYLXSA-N pentostatin Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC[C@H]2O)=C2N=C1 FPVKHBSQESCIEP-JQCXWYLXSA-N 0.000 description 1
• 229960002340 pentostatin Drugs 0.000 description 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
• 108030002458 peroxiredoxin Proteins 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 230000002974 pharmacogenomic effect Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000037081 physical activity Effects 0.000 description 1
• XESARGFCSKSFID-FLLFQEBCSA-N pirazofurin Chemical compound OC1=C(C(=O)N)NN=C1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XESARGFCSKSFID-FLLFQEBCSA-N 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 229910052697 platinum Inorganic materials 0.000 description 1
• 229960003171 plicamycin Drugs 0.000 description 1
• 108010056274 polo-like kinase 1 Proteins 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920000642 polymer Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
• 238000012342 propidium iodide staining Methods 0.000 description 1
• 208000020016 psychiatric disease Diseases 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• JFINOWIINSTUNY-UHFFFAOYSA-N pyrrolidin-3-ylmethanesulfonamide Chemical compound NS(=O)(=O)CC1CCNC1 JFINOWIINSTUNY-UHFFFAOYSA-N 0.000 description 1
• 239000012857 radioactive material Substances 0.000 description 1
• 238000003127 radioimmunoassay Methods 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 238000007634 remodeling Methods 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 238000003571 reporter gene assay Methods 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 108020004418 ribosomal RNA Proteins 0.000 description 1
• 229960004641 rituximab Drugs 0.000 description 1
• 102220057217 rs730881149 Human genes 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 229940072272 sandostatin Drugs 0.000 description 1
• 230000000276 sedentary effect Effects 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 208000019694 serous adenocarcinoma Diseases 0.000 description 1
• 208000004548 serous cystadenocarcinoma Diseases 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 238000009097 single-agent therapy Methods 0.000 description 1
• 238000002603 single-photon emission computed tomography Methods 0.000 description 1
• AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 108010090953 subunit 1 GABA type B receptor Proteins 0.000 description 1
• 229960001796 sunitinib Drugs 0.000 description 1
• WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 description 1
• 230000003319 supportive effect Effects 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 238000011477 surgical intervention Methods 0.000 description 1
• 229940120982 tarceva Drugs 0.000 description 1
• DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 229960001196 thiotepa Drugs 0.000 description 1
• 229960002175 thyroglobulin Drugs 0.000 description 1
• 229960003087 tioguanine Drugs 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 229940044693 topoisomerase inhibitor Drugs 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 108010014677 transcription factor TFIIE Proteins 0.000 description 1
• 108091006106 transcriptional activators Proteins 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• NOYPYLRCIDNJJB-UHFFFAOYSA-N trimetrexate Chemical compound COC1=C(OC)C(OC)=CC(NCC=2C(=C3C(N)=NC(N)=NC3=CC=2)C)=C1 NOYPYLRCIDNJJB-UHFFFAOYSA-N 0.000 description 1
• 229960001099 trimetrexate Drugs 0.000 description 1
• 150000003641 trioses Chemical class 0.000 description 1
• 230000004565 tumor cell growth Effects 0.000 description 1
• 231100000588 tumorigenic Toxicity 0.000 description 1
• 230000000381 tumorigenic effect Effects 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
• HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 229960000653 valrubicin Drugs 0.000 description 1
• ZOCKGBMQLCSHFP-KQRAQHLDSA-N valrubicin Chemical compound O([C@H]1C[C@](CC2=C(O)C=3C(=O)C4=CC=CC(OC)=C4C(=O)C=3C(O)=C21)(O)C(=O)COC(=O)CCCC)[C@H]1C[C@H](NC(=O)C(F)(F)F)[C@H](O)[C@H](C)O1 ZOCKGBMQLCSHFP-KQRAQHLDSA-N 0.000 description 1
• 210000005048 vimentin Anatomy 0.000 description 1
• 229960004355 vindesine Drugs 0.000 description 1
• UGGWPQSBPIFKDZ-KOTLKJBCSA-N vindesine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(N)=O)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 UGGWPQSBPIFKDZ-KOTLKJBCSA-N 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 229940033942 zoladex Drugs 0.000 description 1